FDA Roadmap Confirms It: Organ-on-a-Chip Is the Future

We’re excited to see regulatory agencies like the FDA lay out a clear roadmap to reduce animal testing in preclinical safety studies – with Organ-on-a-Chip (OoC) technologies playing a central role.  
 
At VitrofluidiX, we’re committed to making human-relevant testing accessible: 
Our all-in-one OoC laboratory device creates the reproducible microenvironment required for OoC to simulate human organ functions – without additional instruments.  
We also do not provide our own chip types or cell types – we can supply a wide variety of chip models, which means we can be used in a wide range of areas. 
 
This roadmap confirms what we believe: OoC is not just a vision – it’s a key enabler of safer, faster, and more ethical drug development. 
Our mission is to make OoC a standard in research and development, and this marks an important milestone on that path.